Payden & Rygel Investment Group Pfizer Inc Transaction History
Payden & Rygel Investment Group
- $1.24 Billion
- Q2 2024
A detailed history of Payden & Rygel Investment Group transactions in Pfizer Inc stock. As of the latest transaction made, Payden & Rygel Investment Group holds 29,980 shares of PFE stock, worth $753,397. This represents 0.07% of its overall portfolio holdings.
Number of Shares
29,980
Previous 270,380
88.91%
Holding current value
$753,397
Previous $7.5 Million
88.82%
% of portfolio
0.07%
Previous 0.35%
Shares
5 transactions
Others Institutions Holding PFE
# of Institutions
3,256Shares Held
3.62BCall Options Held
77.2MPut Options Held
122M-
Vanguard Group Inc Valley Forge, PA516MShares$13 Billion0.27% of portfolio
-
Black Rock Inc. New York, NY424MShares$10.7 Billion0.27% of portfolio
-
State Street Corp Boston, MA290MShares$7.3 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA164MShares$4.11 Billion0.85% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA130MShares$3.27 Billion0.73% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $141B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...